Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksREDX.L Share News (REDX)

  • There is currently no data for REDX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK EXECUTIVE CHANGE SUMMARY: InnovaDerma CEO Steps Down Immediately

Wed, 05th Aug 2020 15:11

(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Wednesday and not separately reported by Alliance News:

----------

InnovaDerma PLC - London-based beauty, personal care and life science products - Kieran Callan steps down as chief executive officer with immediate effect, "by mutual agreement with the board". Executive Chair Joe Bayer will be interim CEO as well until a replacement CEO is found. Financial Controller Warren Dockary is promoted to chief financial officer, reporting to the board.

----------

SolGold PLC - copper and gold in Ecuador - Brian Moller steps down as chair, replaced by independent non-executive director Liam Twigger. Moller will remain as a non-executive director. Twigger was a founding partner for establishing Macquarie Bank in Perth. SolGold also says Robert Weinberg will retire as non-executive director at the company's annual general meeting, last year held in September.

----------

Redx Pharma PLC - Macclesfield, England-based drug discovery and development - Tom Burt joins as non-executive director, effective from Tuesday, to represent shareholder Sofinnova Partners, where he is a partner in the Crossover fund. Burt previously was a research analyst at Peel Hunt.

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
9 Sep 2020 12:26

Redx signs new collaboration deal with Jazz Pharmaceuticals

(Sharecast News) - Drug discovery and development company Redx Pharma has signed a new research collaboration agreement with Jazz Pharmaceuticals to discover and develop drug candidates for two cancer targets on the Ras/Raf/MAP kinase (MAPK) pathway.

Read more
4 Aug 2020 13:58

IN BRIEF: Redx Pharma Inks Licencing Agreement With AstraZeneca

IN BRIEF: Redx Pharma Inks Licencing Agreement With AstraZeneca

Read more
4 Aug 2020 08:45

Redx Pharma surges on AstraZeneca licensing agreement

(Sharecast News) - Redx Pharma shares soared on Tuesday after it signed a licensing agreement with AstraZeneca for its porcupine inhibitor for fibrotic diseases, RXC006.

Read more
1 Jul 2020 17:15

UK DIRECTOR DEALINGS SUMMARY: Braveheart Buys Stake In RMS From Brown

UK DIRECTOR DEALINGS SUMMARY: Braveheart Buys Stake In RMS From Brown

Read more
30 Jun 2020 14:47

IN BRIEF: Redx Pharma Plans USD30 Million Fundraise; Loss Narrows

IN BRIEF: Redx Pharma Plans USD30 Million Fundraise; Loss Narrows

Read more
18 May 2020 14:39

UK EXECUTIVE CHANGE SUMMARY: FastForward Innovations Names Chair, CEO

UK EXECUTIVE CHANGE SUMMARY: FastForward Innovations Names Chair, CEO

Read more
1 May 2020 14:36

Redmile Acquires Additional 34% Stake In Redx As Offer Closes

Redmile Acquires Additional 34% Stake In Redx As Offer Closes

Read more
23 Apr 2020 15:40

UK TRADING UPDATE SUMMARY: Braemar Says Oil Tankers Wanted For Storage

UK TRADING UPDATE SUMMARY: Braemar Says Oil Tankers Wanted For Storage

Read more
9 Apr 2020 18:38

Redmile Buys Further 24.1 Million Redx Shares, Now Holds 58% Stake

Redmile Buys Further 24.1 Million Redx Shares, Now Holds 58% Stake

Read more
2 Apr 2020 18:32

Redmile Ups Redx Pharma Stake, Buys Further 24 Million Shares

Redmile Ups Redx Pharma Stake, Buys Further 24 Million Shares

Read more
30 Mar 2020 17:04

Redx Pharma Secures GBP5 Million Loan From Redmile Group

Redx Pharma Secures GBP5 Million Loan From Redmile Group

Read more
13 Mar 2020 10:58

UK WINNERS & LOSERS SUMMARY: Premier Oil Up As It Retains Guidance

UK WINNERS & LOSERS SUMMARY: Premier Oil Up As It Retains Guidance

Read more
13 Mar 2020 10:31

Redx shares surge on possible cash offer from Yesod

(Sharecast News) - Drug discovery and development company Redx Pharma has received a further private approach from Yesod Bio-Sciences, it announced on Friday, that could lead to a possible cash offer for the entire issued and to be issued share capital of the company, at a price of 15p per share.

Read more
13 Mar 2020 09:26

Shares Soar As Redx Pharma Receives Two Acquisition Offers, Agrees One

Shares Soar As Redx Pharma Receives Two Acquisition Offers, Agrees One

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.